Activist investor Elliott takes big stake in drugmaker Catalent – WSJ

This post was originally published on this site

https://i-invdn-com.investing.com/trkd-images/LYNXMPEJ6I0YW_L.jpg

Elliott has been talking to potential director candidates about joining a slate of nominees to run in a proxy contest, WSJ said, citing people familiar with the matter.

The exact size of Elliott’s stake in Catalent could not be learned, WSJ added. Catalent has a market capitalization of $8.35 billion.

Elliott and Catalent did not immediately respond to Reuters requests for comment.